02

Dec

EU regulator begins real-time review of Valneva’s COVID-19 shot

Dec 2 (Reuters) - The European Union's (EU) drug regulator said on Thursday it had started a rolling review of the protein-based COVID-19 vaccine from French biotech firm Valneva ,…

Read More Here

10

Nov

EU signs eighth COVID-19 vaccine deal with France’s Valneva

Nov 10 (Reuters) - The European Commission on Wednesday agreed to buy up to 60 million doses of French biotech company Valneva's potential COVID-19 vaccine, the eight such deal by…

Read More Here

01

May

Some EU nations still want Valneva COVID-19 vaccine deal – sources

PARIS, April 30 (Reuters) - Some EU countries still want Brussels to strike a deal to buy Valneva's COVID-19 vaccine candidate despite a recent setback in talks, as the bloc aim…

Read More Here

12

Jan

EU concludes exploratory talks with Valneva to secure a new potential vaccine

BRUSSELS (Reuters) - The European Union said on Tuesday it had concluded exploratory talks with the French drugmaker Valneva for the supply of up to 60 million doses of its…

Read More Here

11

Jan

EXCLUSIVE – EU seeks more Moderna COVID-19 vaccines, eyes deals with Valneva, Novavax

BRUSSELS/MILAN, Jan 11 (Reuters) - The European Union is in talks with Moderna to order more of its COVID-19 vaccine despite the company seeking a higher price, and is also…

Read More Here

16

Dec

Valneva to start clinical trials of COVID-19 vaccine candidate in UK

French pharmaceutical firm Valneva will start the first clinical trials of its COVID-19 vaccine candidate at four sites in England, Britain's business ministry said on Wednesday. The Phase I and…

Read More Here

14

Sep

Valneva to supply up to 190 million doses of COVID-19 vaccine to UK

French vaccine maker Valneva said on Monday it would supply the UK with up to 190 million doses of its coronavirus vaccine candidate, VLA2001, over a five-year period. Under the…

Read More Here